# Ca-Mg Butyrate in GWI

> **NCT05367245** · PHASE2 · RECRUITING · sponsor: **VA Office of Research and Development** · enrollment: 120 (estimated)

## Conditions studied

- Gulf War Illness
- Chronic Fatigue
- Neurocognitive Dysfunction

## Interventions

- **DRUG:** Cal-Mag Butyrate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05367245
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-15
- **Primary completion:** 2026-10-10
- **Final completion:** 2027-03-31
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2025-10-31

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05367245

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05367245, "Ca-Mg Butyrate in GWI". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05367245. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*